(The per-serving costs are for the label-recommended doses
In a nutshell, these numerous concurrent N-3 PUFAs-mediated mechanisms increase neuronal robustness against neurodegenerative cascades and can be regarded as key dietary modulators of brain health 30
Paulus WJ, Tschpe C
Yang, B., Fan, S., Zhi, X., Li, Y., Liu, Y., Wang, D., He, M., Hou, Y., Zheng, Q., & Sun, G
In new results released Thursday on type 2 diabetes, with which patients tend to lose less weight with medications, Lilly said the drug lowered A1C blood sugar levels by an average of 1.7% to 2% at 40 weeks and produced average weight loss of up to 17%, or about 37 pounds
However, studies on tirzepatide (dual GLP-1/GIP agonist) demonstrate that patients switching from plateaued GLP-1 therapy regain significant weight losssuggesting the plateau reflects adaptation to single-pathway activation rather than true medication failure